Article
Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metalloproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants.
Cancer research - 15 Feb 2005
Vosseler Silvia, Mirancea Nicolae, Bohlen Peter, Mueller Margareta M, Fusenig Norbert E
Abstract excerpt
Inhibition of vascular endothelial growth factor (VEGF) signaling, a key regulator of tumor angiogenesis, through blockade of VEGF receptor (VEGFR)-2 by the monoclonal antibody DC101 inhibits angiogenesis, tumor growth, and invasion. In a surface xenotransplant assay on nude mice using a high-grade malignant squamous cell carcinoma cell line (A-5RT3), we show that DC101 causes vessel regression and normalization...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.